These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3985990)

  • 1. Interaction of streptomycin and streptomycylamine derivatives with negatively charged lipid layers. Correlation between binding, conformation of complexes and inhibition of lysosomal phospholipase activities.
    Brasseur R; Carlier MB; Laurent G; Claes PJ; Vanderhaeghe HJ; Tulkens PM; Ruysschaert JM
    Biochem Pharmacol; 1985 Apr; 34(7):1035-47. PubMed ID: 3985990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of acidic phospholipids on the activity of lysosomal phospholipases and on their inhibition by aminoglycoside antibiotics--I. Biochemical analysis.
    Mingeot-Leclercq MP; Piret J; Brasseur R; Tulkens PM
    Biochem Pharmacol; 1990 Aug; 40(3):489-97. PubMed ID: 2383282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of aminoglycoside antibiotics with negatively charged lipid layers. Biochemical and conformational studies.
    Brasseur R; Laurent G; Ruysschaert JM; Tulkens P
    Biochem Pharmacol; 1984 Feb; 33(4):629-37. PubMed ID: 6704179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of acidic phospholipids on the activity of lysosomal phospholipases and on their inhibition induced by aminoglycoside antibiotics--II. Conformational analysis.
    Mingeot-Leclercq MP; Piret J; Tulkens PM; Brasseur R
    Biochem Pharmacol; 1990 Aug; 40(3):499-506. PubMed ID: 2383283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of lysosomal phospholipases by aminoglycoside antibiotics: in vitro comparative studies.
    Carlier MB; Laurent G; Claes PJ; Vanderhaeghe HJ; Tulkens PM
    Antimicrob Agents Chemother; 1983 Mar; 23(3):440-9. PubMed ID: 6847172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical mechanism of aminoglycoside-induced inhibition of phosphatidylcholine hydrolysis by lysosomal phospholipases.
    Mingeot-Leclercq MP; Laurent G; Tulkens PM
    Biochem Pharmacol; 1988 Feb; 37(4):591-9. PubMed ID: 3342096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructural, physico-chemical and conformational study of the interactions of gentamicin and bis(beta-diethylaminoethylether) hexestrol with negatively-charged phospholipid layers.
    Mingeot-Leclercq MP; Schanck A; Ronveaux-Dupal MF; Deleers M; Brasseur R; Ruysschaert JM; Laurent G; Tulkens PM
    Biochem Pharmacol; 1989 Mar; 38(5):729-41. PubMed ID: 2539158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin.
    Laurent G; Carlier MB; Rollman B; Van Hoof F; Tulkens P
    Biochem Pharmacol; 1982 Dec; 31(23):3861-70. PubMed ID: 7159463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro inhibition of lysosomal phospholipases by aminoglycoside antibiotics: a comparative study.
    Carlier MB; Laurent G; Tulkens P
    Arch Toxicol Suppl; 1984; 7():282-5. PubMed ID: 6595993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of kidney lysosomal phospholipases A and C by aminoglycoside antibiotics: possible mechanism of aminoglycoside toxicity.
    Hostetler KY; Hall LB
    Proc Natl Acad Sci U S A; 1982 Mar; 79(5):1663-7. PubMed ID: 6951205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular parameters involved in aminoglycoside nephrotoxicity.
    Mingeot-Leclercq MP; Brasseur R; Schanck A
    J Toxicol Environ Health; 1995 Mar; 44(3):263-300. PubMed ID: 7897692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of kidney lysosomal phospholipase A1 by aminoglycosides is a novel variant of substrate depletion inhibition.
    Hostetler KY; Jellison EJ
    J Pharmacol Exp Ther; 1990 Jul; 254(1):188-91. PubMed ID: 2366181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accessibility of aminoglycosides, isolated and in interaction with phosphatidylinositol, to water. A conformational analysis using the concept of molecular hydrophobicity potential.
    Mingeot-Leclercq MP; Tulkens PM; Brasseur R
    Biochem Pharmacol; 1992 Nov; 44(10):1967-75. PubMed ID: 1449515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of substrate organization on the activity and on the mechanism of gentamicin-induced inhibition of rat liver lysosomal phospholipase A1.
    Piret J; Kishore BK; Tulkens PM
    Biochem Pharmacol; 1992 Feb; 43(4):895-8. PubMed ID: 1540243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoglycoside antibiotics inhibit lysosomal phospholipase A and C from rat liver in vitro.
    Hostetler KY; Hall LB
    Biochim Biophys Acta; 1982 Mar; 710(3):506-9. PubMed ID: 7074128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New derivatives of kanamycin B obtained by modifications and substitutions in position 6''. 2. In vitro and computer-aided toxicological evaluation with respect to interactions with phosphatidylinositol.
    Mingeot-Leclercq MP; Van Schepdael A; Brasseur R; Busson R; Vanderhaeghe HJ; Claes PJ; Tulkens PM
    J Med Chem; 1991 Apr; 34(4):1476-82. PubMed ID: 2016725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. I. Polyaspartic acid binds gentamicin and displaces it from negatively charged phospholipid layers in vitro.
    Kishore BK; Kállay Z; Lambricht P; Laurent G; Tulkens PM
    J Pharmacol Exp Ther; 1990 Nov; 255(2):867-74. PubMed ID: 2243355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of the macrolide azithromycin with phospholipids. I. Inhibition of lysosomal phospholipase A1 activity.
    Van Bambeke F; Montenez JP; Piret J; Tulkens PM; Courtoy PJ; Mingeot-Leclercq MP
    Eur J Pharmacol; 1996 Oct; 314(1-2):203-14. PubMed ID: 8957238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of macrolide antibiotics (Erythromycin A, roxithromycin, erythromycylamine [Dirithromycin], and azithromycin) with phospholipids: computer-aided conformational analysis and studies on acellular and cell culture models.
    Montenez JP; Van Bambeke F; Piret J; Brasseur R; Tulkens PM; Mingeot-Leclercq MP
    Toxicol Appl Pharmacol; 1999 Apr; 156(2):129-40. PubMed ID: 10198278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cationic amphiphilic drugs on the hydrolysis of acidic and neutral phospholipids by liver lysosomal phospholipase A.
    Pappu A; Hostetler KY
    Biochem Pharmacol; 1984 May; 33(10):1639-44. PubMed ID: 6732837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.